Je was op zoek naar: proinflammatory (Engels - Estisch)

for oclacitinib, the target cytokines are those that are proinflammatory or have a role in allergic responses/pruritis.
oklatsitiniib mõjutab proinflammatoorseid ja allergilistes reaktsioonides / kiheluses osalevaid tsütokiine.

as a result, secukinumab inhibits the release of proinflammatory cytokines, chemokines and mediators of tissue damage and reduces il-17a-mediated contributions to autoimmune and inflammatory diseases.
selle tulemusena inhibeerib sekukinumab proinflammatoorsete tsütokiinide, kemokiinide ja koekahjustuse mediaatorite vabanemist ning vähendab il-17a vahendatud toimeid autoimmuunsete ja põletikuliste haiguste puhul.

these include inhibiting the release of proinflammatory cytokines such as il-4, il-6, il-8, and il-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule p-selectin on endothelial cells.
desloratadiin pärsib põletikule eelnevate tsütokiinide il-4, il-6, il-8 ja il-13 vabanemist inimese nuumrakkudest/basofiilidest ning pärsib adhesioonimolekul p-selektiini ekspressiooni endoteeli rakkudes.